In a commentary in the November issue of The American Journal of Managed Care® (AJMC®), health policy and health economics researchers make three recommendations to improve how healthcare system decision makers assess the value of new, potentially costly medical technologies, in light of growing concerns from payers, employers, patients, and other stakeholders.
November 14, 2018
· 2 min read